Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
VSGN - News -Vasogen to Conduct Year-end Conference Call
PR Newswire - February 07, 2006 08:02
TORONTO, Feb 07, 2006 /PRNewswire-FirstCall via COMTEX/ -- Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), a leader in the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, will release its year-end results after the close of the North American financial markets on Tuesday, February 14, 2006. A conference call will follow at 4:30 p.m. Eastern Time, during which management will provide a company update and discuss year-end results. Participants are invited to attend by connecting 10 minutes prior to the call to one of the following:
------------------------------------------------
Audio Web Cast(x) www.vasogen.com
------------------------------------------------
Direct Dial 416-695-5261
------------------------------------------------
Toll-free 1-877-461-2816
------------------------------------------------
A re-broadcast of the conference call may be accessed by:
------------------------------------------------
Audio Web Cast(x) www.vasogen.com
------------------------------------------------
Direct Dial 1-877-605-9320
Pin code: 9070
------------------------------------------------
ONSM- News; Onstream Media Awarded GSA Contract
PR Newswire - February 07, 2006 08:02
POMPANO BEACH, Fla., Feb 07, 2006 /PRNewswire-FirstCall via COMTEX/ -- Continuing to build on its commitment to the government sector, Onstream Media Corporation (Nasdaq: ONSM) today announced it has been awarded a five year Government Services Administration (GSA) Schedule contract #GS-35F-0211S, effective immediately. This contract provides a purchase mechanism for government agencies to directly procure the company's digital media service applications easily and affordably.
The Onstream Media services are available through the GSA Federal Supply Service (FSS) Information Technology Schedule. They include Onstream Media's Digital Media Service Platform, webcasting, web conferencing, encoding and audio and video collaboration and bridging. GSA's Federal Supply Service manages the largest, most diverse and innovative federal marketplace in the world, bringing hundreds of thousands of federal customers together with its contractors.
"We are excited to have been awarded a contract from GSA," said Randy Selman, President and CEO of Onstream Media. "Onstream Media is proud to join GSA in its commitment to simplifying the acquisition process. Our products are already utilized by several state and federal agencies that include the Federal Reserve, Department of State, The House of Representatives, Department of Homeland Security, and the Department of Veterans Affairs, confirming that Onstream Media is well-positioned to address the unique needs of the government sector. As a result the GSA FSS contract should further enhance and strengthen our government relationships."
About Onstream Media Corporation
Founded in 1993, Onstream Media (Nasdaq: ONSM) is a leading online Application Service Provider (ASP) of live and on-demand, rich media communications via the Onstream Digital Media Services Platform. Specializing in audio and video corporate communications, Onstream Media's pioneering ASP digital media services technology provides its customers with the necessary tools for webcasting, web conferencing, managing digital assets, publishing content on the Internet and establishing e-commerce storefronts to transact business online. All of Onstream Media's services are focused on increasing productivity and revenues, and reducing capital expenditures and operational costs of any organization in an affordable and highly secure environment. As a result, 78% of the Fortune 100 CEOs and CFOs and almost half of the Fortune 1000 companies have used Onstream Media's services.
Onstream Media customers include: AOL, AAA, AXA Equitable Life Insurance Company, Disney, MGM, Deutsche Bank, Thomson Financial/CCBN, PR Newswire and the U.S. Government.
For more information, visit the Onstream website at http://www.onstreammedia.com or call 954-917-6655.
This press release contains forward-looking statements, some of which may relate to Onstream Media Corporation and which involve numerous risks and uncertainties. Actual results, performance or achievements could differ materially from those anticipated in such forward-looking statements as a result of certain factors, including those set forth in Onstream Media Corporation's filings with the Securities and Exchange Commission.
For More Information:
Howard Gostfrand
American Capital Ventures
305-918-7000
hg@amcapventures.com
Sheri Seybold
Big Sky Communications
925-556-9197
sheri@bigskypr.com
SOURCE Onstream Media Corporation
Howard Gostfrand, American Capital Ventures, +1-305-918-7000, or
hg@amcapventures.com, or Sheri Seybold, Big Sky Communications, +1-925-556-9197, or
sheri@bigskypr.com, for Onstream
http://www.prnewswire.com
Copyright (C) 2006 PR Newswire. All rights reserved.
--------------------------------------------------------------------------------
Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision.
Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
CYBL - News; National Catalog and Online Retailers to Sell Cyberlux's EverOn Emergency Light
PR Newswire - February 07, 2006 07:30
RESEARCH TRIANGLE PARK, N.C., Feb 07, 2006 /PRNewswire-FirstCall via COMTEX/ -- Cyberlux Corporation (OTC Bulletin Board: CYBL), announces that two national catalog and online retailers will offer Cyberlux's EverOn Emergency and Multi-Purpose LED light to more than 10 million customers.
The EverOn Emergency and Multi-Purpose light, endorsed by a south Florida Emergency Management organization, is a sturdy, virtually indestructible, portable, solid-state LED lighting product that provides over 60 hours of comfortable room-filling light on the medium setting, and over 30 hours of intensely bright white light on the highest setting; all in a compact 7 inch by 3.5 inch by 2.4 inch package using four AA batteries.
Conventional emergency lighting sources such as flashlights, last three to five hours on one set of batteries and are unreliable and inefficient. Candles and open flame lanterns are dangerous. The EverOn's energy-efficient diodal lighting elements are powered and controlled by a patented solid state, integrated circuit that precisely controls the flow of electricity to the lighting elements, unlike conventional flashlights or lanterns that use a simple switch to connect batteries to the bulbs or tubes.
Light Emitting Diodes (LEDs) are durable, energy efficient, cool to the touch, and last more than 100 times longer than conventional incandescent lights. The solid-state semiconductors are typically used in automobile dashboards and electronic devices, such as mobile phones. In addition to the EverOn, Cyberlux has developed a range of LED lighting products for residential, commercial, military and homeland security markets.
A national and catalog retailer since 1986, Solutions Catalog (www.solutionscatalog.com) will be offering the EverOn as a part of their unique practical products that solve everyday challenges around the home, and that offer a good value. Solutions is part of Norm Thompson Outfitters, a leader in direct mail and retail since 1949.
Stacks and Stacks (www.stacksandstacks.com), founded in 1984 in the San Francisco Bay Area, is a nationally recognized retail, catalog and internet company that offers over 12,000 practical, stylish and affordable products for the home, office, garden and automobile. Stacks and Stacks will also be offering the EverOn to their customers.
"Consumers are discovering new, long-lasting lighting solutions such as the EverOn to use during power outages such as the ones that occurred during the hurricanes last year," said William Walker, Cyberlux Corporation's vice president of sales. "A source of emergency light is a great comfort and a measure of safety when the power goes out. The EverOn lasts longer than conventional incandescent flashlights and is a much better and safer solution than candles during power outages. It is sturdy and compact, easily carried in the palm of a hand, and it can also be used for many other purposes, such as camping and boating."
Emergency Management officials in Collier County, Fl., has relied on the EverOn as an emergency lighting source in hurricane shelters and for victims needing medical assistance, and plan to use it as a standard product in their disaster relief inventory
Good Mourning T Toon & Stockz,
MZT - NEWS; Matritech Reports Record Revenues for Fourth Quarter and 2005; NMP22(R) BladderChek(R) Test Revenues Increase 72% for Year
Business Wire - February 07, 2006 07:00
NEWTON, Mass., Feb 07, 2006 (BUSINESS WIRE) -- Matritech (Amex: MZT), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the fourth quarter and fiscal year ended December 31, 2005. Revenues from sales of the NMP22(R) BladderChek(R) Test in 2005 increased 72% over those reported in 2004, and achieved previously issued 2005 guidance.
David L. Corbet, Matritech's President and COO remarked, "Recognition by preeminent urologists of the clinical benefits the NMP22(R) BladderChek(R) Test contributed to the impressive sales growth of this product during 2005. During the past 12 months, the BladderChek(R) Test was featured in two major studies published in the Journal of the American Medical Association (JAMA) and three new CME (Continuing Medical Education) programs - two initiated by the University of Pennsylvania and one by the American Urological Association (AUA). Our objective of establishing the NMP22(R) BladderChek(R) Test as a standard of care has been significantly advanced by these and other positive articles and presentations. During 2006, we expect there will be additional presentations demonstrating the clinical benefits of the NMP22(R) BladderChek(R) Test. We intend to continue to make use of all these endorsements of the effectiveness of the BladderChek(R) Test to increase product usage by urologists as well as begin promoting the NMP22(R) BladderChek(R) Test to other physician groups in the U.S."
Revenues for the fourth quarter of 2005 were $2,818,000 compared with $2,432,000 for the fourth quarter of 2004, an increase of 16%. Revenue recognized from sales of the NMP22(R) BladderChek(R) Test increased 38% during the quarter to $2,254,000 compared to $1,632,000 in the fourth quarter of 2004. Overall product sales for the fourth quarter of 2005 were $2,776,000 compared with $2,382,000 for the fourth quarter of 2004. NMP22(R) BladderChek(R) Test sales accounted for approximately 90% of sales in the NMP22(R) product line.
The Company reported a loss from operations of $1,795,000 for the fourth quarter of 2005 compared with a loss from operations of $1,853,000 for the same period in 2004. This 3% decrease was mainly the result of increased sales of NMP22(R) BladderChek(R) Test. The Company reported a net loss of $2,218,000 or $0.05 per share for the fourth quarter of 2005, compared with a loss of $2,490,000 or $0.06 per share for the same period in 2004.
Revenues for the year ended December 31, 2005 were $10,415,000 compared with $7,483,000 for the year ended December 31, 2004, an increase of 39%. Revenue recognized from the sales of the NMP22(R) BladderChek(R) Test increased 72% during the year 2005 to $7,686,000 as compared with $4,466,000 in 2004. Overall product sales for 2005 were $10,290,000 compared to $7,275,000 for the year 2004.
The Company reported a loss from operations of $7,730,000 for the year ended December 31, 2005 compared with a loss of $8,368,000 for the year 2004. The Company reported a net loss attributable to common shareholders of $9,492,000 or $0.21 per share for year ended December 31, 2005 compared with a net loss of $11,123,000 or $0.27 per share for 2004. The reported net loss attributable to common shareholders for 2005 includes a $1,627,000 non-cash charge attributable to the beneficial conversion feature of the Series A Convertible Preferred Stock financing which closed in the first quarter of 2005 offset by a non-cash gain of $1,900,000
EMA - NEWs - eMagin Extends Sales Channels in Asia, Europe and Canada
Business Wire - February 07, 2006 06:41
BELLEVUE, Wash., Feb 07, 2006 (BUSINESS WIRE) -- eMagin Corporation (AMEX:EMA), a leader in personal display systems and OLED microdisplay technology, is extending its markets in Europe and Asia through the use of direct distributors for its award-winning Z800 3DVisor.
Kisense International, Xi'an, China has purchased initial inventory and has agreed to distribute the Z800 3DVisor in China. In Europe, eMagin has signed several partners to sell the product, including RM Ingenierie, Cedex, France; Inition, London, UK; and Cnoti, Portugal. In addition, eMagin currently has three distributors in Canada: TekGear, Winnipeg; CyberWorld, Inc., Toronto; and Les technologies 3vis, Inc., Montreal, Canada. Until now, the Z800 3DVisor has primarily been available only through direct sales from eMagin's own website, www.3dvisor.com, and recently through Amazon.com.
"Interest in our Z800 3DVisor continues to grow as a result of our strong showing at the January Consumer Electronics Show in Las Vegas, where the product was awarded the coveted Best of Innovations award for the display category," said Susan Jones, executive vice president and chief marketing officer. "To capitalize on this interest we are expanding our distribution through the addition of several highly qualified direct partners. Today's announcement covers the first seven."
eMagin's Z800 3DVisor delivers a high-color, high-contrast virtual image equivalent to a 105-inch screen viewed at twelve feet, in full-color stereovision. The Z800's high-speed headtracking provides full 360-degree viewing, enabling users to look around in the virtual world just as they would look around the real world. Completing the near-immersive experience is an integrated audio system with stereo earbuds and a noise-canceling microphone. To power all these capabilities, the Z800 3DVisor requires only a standard USB port and can greatly extend a laptop's battery life when it's used instead of the standard LCD laptop screen.
About
Stockz4O You are coming up with them tonight aren't You, CITC sounds very interesting
TGEN - News - DJ Targeted Genetics Starts Phase II HIV/AIDS Vaccine Trial
TCOM - News - TCOM Announces Alpha Century to Open Five Offices in March In China, Focuses One Million SMEs Internet Business Services Market
PR Newswire - February 06, 2006 10:51
HONG KONG, Feb 06, 2006 /Xinhua-PRNewswire via COMTEX/ -- Telecom Communications, Inc. (OTC Bulletin Board: TCOM - News) the Total Solutions Provider, announced today that its subsidiary, Alpha Century Holdings Limited (Alpha), plans to open an office in Beijing, Guangdong, Zhejiang, Hunan and Chongqing in March.
"We plan to launch five offices in China to provide full services to SME's internet business services of IBS v5.0 and Subaye.com value chain, which has received more than 100,000 SME sales leads in China that are moving fast into B-B-C e-commerce market through internet business services of IBS v5.0," said Tim Chen, CEO of TCOM. "We believe that we will add 100,000 SME members to our Subaye.com during this year alone."
About Telecom Communications, Inc.
Telecom Communications, Inc. is a Total Solutions Provider that offers Integrated Communications Network Solutions and Internet Content Services in universal voice, video, data web and mobile communications for interactive media applications, technology and content leaders in interactive multimedia communications. It develops, markets and sells a universal media software solution for enterprise-wide deployment of integrated voice, video, data web and mobile communications and media applications. Telecom Communications, Inc. does business in Asia via its wholly owned subsidiaries, Alpha Century Holdings Ltd and 3G Dynasty Inc. (http://www.icstarmms.com ; http://www.skyestar.com ). icstarmms.com currently provides entertainment contents to 64 China internet companies including: www.Baidu.com , Shanghai Linktone, 3721.com -- a Yahoo company, Kongzhong Corp., www.QQ.com and www.eLong.com under the cooperation partnership agreements. About IBS v4.1 Enterprise Suite The product line focuses on the one million SMEs in China, with version 4.1 enterprise suite being satiable to all companies with less than 500 employees, inner information resource management and affiliate networks, vendor/customer, information process and communications over the internet and wireless communications. This product has strong customer relations and interactive management, straight to the end consumer via MoDirect. Most SMEs have only small budgets for promotion, marketing and customer management. They can use IBS v4.1 at the lowest cost to publish ads on the web and SEO4Mobile mobile phone users. The product allows quick and easy interaction between company and customer straight to the end consumers.
SQNM - News - M. D. Anderson's Kleberg Center Selects Sequenom's MassARRAY(R) System and iPLEX(TM) Assay for Epigenomic Studies and Genotyping
PR Newswire - February 06, 2006 09:01
SAN DIEGO, Feb 06, 2006 /PRNewswire-FirstCall via COMTEX/ -- Sequenom, Inc. (Nasdaq: SQNM) announced today that The University of Texas M. D. Anderson's Kleberg Center for Molecular Markers has purchased Sequenom's proprietary MassARRAY genetic analysis system and iPLEX assay for the Center's molecular marker research and individualized cancer care initiatives.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO )
"We will use Sequenom's technology for genotyping and epigenomic studies in support of our efforts to identify individuals at high risk for developing specific types of cancer, develop screening approaches for early diagnosis of cancer, and tailor therapy to the genetic make-up of each patient," said Gordon Mills, M.D., Ph.D., chair of the Department of Molecular Therapeutics and co-director of the Kleberg Center. "Sequenom's MassARRAY platform is particularly attractive for our needs because it enables us to do many types of studies in a cost-effective manner, on a single platform, e.g., genotyping, quantitative gene expression, and quantitative methylation marker analysis."
"We are proud that Sequenom's technology was chosen by the Kleberg Center for their cancer pharmacogenetic needs and we hope to expand our relationship with this prominent institution in the future," stated Harry Stylli, MBA, Ph.D., President and Chief Executive Officer of Sequenom, Inc. "The MassARRAY system's multi-application versatility and quantitative capabilities differentiate it from other technologies and make it especially well-suited for the demands of cancer research. Our iPLEX assay also answers the needs of leading research organizations such as the Kleberg Center by reducing reagent costs per genotype and offering efficient assay design. We are pleased to see validation of our efforts to provide the most advanced cancer research centers with the most enabling tools."
About The Kleberg Center
Opened in 2005 and based in Houston, Texas, the Robert J. Kleberg, Jr. and Helen C. Kleberg Center for Molecular Markers is part of The University of Texas M.D. Anderson Cancer Center. Under the co-direction of Dr. Mills and Stanley Hamilton, M.D., head of the Division of Pathology and Laboratory Medicine at M. D. Anderson, the Kleberg Center's goal is to individualize treatment by analyzing the changes in genes and proteins that distinguish cancer cells from normal cells and one cancer cell from another. Patient studies are ongoing in leukemia, melanoma, lung cancer, head and neck cancers, ovarian cancer, breast cancer and prostate cancer. By simultaneously analyzing changes in thousands of genes and proteins, Kleberg Center scientists hope to identify patients at high risk for cancer or detect cancers earlier by developing blood, serum and other minimally invasive tests.
About Sequenom
Sequenom is committed to providing the best genetic analysis products that translate genomic science into superior solutions for non-invasive prenatal testing, biomedical research, molecular medicine and agricultural applications. The Company's proprietary MassARRAY system is a high-performance DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations therein. The system is able to deliver reliable and specific data from complex biological samples and from genetic target material that is only available in trace amounts. The Company has exclusively licensed intellectual property rights for the development and commercialization of non-invasive prenatal genetic tests for use with the MassARRAY system and other platforms.
Sequenom(R), MassARRAY(R), iPLEX(TM) are trademarks of Sequenom, Inc.
Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the Kleberg Center's expected use of the MassARRAY system, Sequenom's future relationship with the Kleberg Center and the Kleberg Center's plans to identify high risk individuals, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks detailed from time to time in Sequenom's SEC filings, including Sequenom's Annual Report on Form 10-K for the year ended December 31, 2004, and its most recently filed quarterly report on Form 10-Q. These forward-looking statements are based on current information that is likely to change. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement, and Sequenom undertakes no obligation to revise or update any forward-looking statement to reflect events or circumstances after the issuance of this press release.
SOURCE Sequenom, Inc.
Investor Relations, Clarke Neumann of Sequenom, Inc., +1-858-202-9206,
cneumann@sequenom.com
http://www.prnewswire.com
Copyright (C) 2006 PR Newswire. All rights reserved. ********************************************************************** As of Thursday, 02-02-2006 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated a DOWNTREND on 08-03-2005 for SQNM @ $0.98. (C) 2006 Comtex News Network, Inc. All rights reserved.
--------------------------------------------------------------------------------
Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision.
Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
VERT - News - JohnsonDiversey Selects Verticalnet On-Demand Solutions as Key Component of Procurement Transformation Across Europe, Middle East, Africa (EMA) and North America
Business Wire - February 06, 2006 09:00
Sourcing Directors from EMA and North America to Leverage On-Demand Components of Verticalnet XE Supply Management as Key Enabler in Procurement Transformation Program
MALVERN, Pa., Feb 06, 2006 (BUSINESS WIRE) -- Verticalnet, Inc. (Nasdaq:VERT), a leading provider of on-demand supply management solutions, announced today that JohnsonDiversey, a leading global provider of cleaning and hygiene solutions for the institutional and industrial marketplaces, has selected components of the Verticalnet XE Supply Management Solution suite. JohnsonDiversey will leverage on-demand components of Verticalnet XE to support initiatives focused on improving global sourcing, standardizing the sourcing process, and enhancing spend visibility.
JohnsonDiversey serves customers in the lodging, food service, retail, healthcare, food and beverage sectors as well as building service contractors worldwide. The company has sales of more than $3.2 billion in more than 140 countries. JohnsonDiversey was formed in May 2002 when Racine, Wisconsin-based Johnson Wax Professional acquired DiverseyLever from global food conglomerate Unilever Plc. As a result of the merger of the two companies, JohnsonDiversey has undertaken a transformation of its global procurement processes to realize visibility into overall spending, establish an enterprise-wide structure for procurement, and increase control over key supplier relationships.
"As part of our process to transform procurement on a global basis, we evaluated all the major players in the sourcing and supply management market," says Philippe Agostini, Sourcing Director of JohnsonDiversey in EMA. "We chose Verticalnet based on both company profile and product criteria. Verticalnet impressed the team because of the breadth of its expertise, their commitment to the success of our project, and the strength of their customer references. On a product level, it was critical that we have a sourcing platform that is easy to use, offers on-demand delivery of a complete supply management solution, and has customer supported proof points for improving and standardizing global sourcing processes." Mr. Agostini concludes, "Verticalnet met our product requirements by offering capabilities that will enable our aggressive transformation of procurement and eSourcing throughout the enterprise."
JohnsonDiversey will deploy Verticalnet XE Spend Manager, Program Manager and Negotiation Manager simultaneously across Europe, Middle East & Africa. In North America, JohnsonDiversey will role out XE Program Manager and Negotiation Manager to further leverage the on-demand capabilities of the Verticalnet XE Supply Management suite. Phased training, coaching and rollout have been initiated as of January, 2006 and are focused on more than 100 buyers worldwide to realize the objectives of the procurement transformation at JohnsonDiversey.
"We are very pleased that industry-leading JohnsonDiversey has made Verticalnet and our XE Supply Management Solution Suite the technology focus of its broad plan to transform procurement across Europe, the Middle East, Africa and North America," stated Nathanael V. Lentz, President and CEO of Verticalnet. "In many enterprises as in JohnsonDiversey, mergers and acquisitions have created the need for the consolidation and transformation of the procurement process in order to take full advantage of all the synergies possible by combining businesses. The fact that the entire XE suite is on-demand also means that our customer will be able to see results sooner without lengthy software implementations and costly software upgrades." Lentz concludes, "We are excited to be part of the success story at JohnsonDiversey."
HIV Bad News - Calypte Biomedical Notified by the American Stock Exchange
By PR Newswire
Last Update: 2/3/2006 6:00:28 PM Data provided by
Feb 03, 2006 /PRNewswire-FirstCall via COMTEX/ -- Calypte Biomedical Corporation (HIV) announced today that on February 2, 2006 it received notice from the American Stock Exchange (the "Exchange") indicating that the Company no longer complies with the Exchange's continued listing standards set forth in the Exchange's Company Guide. Specifically, the Exchange noted that the Company is not in compliance with Section 1003(a)(i) with shareholders' equity of less than $2,000,000 and losses from continuing operations and/or net losses in two out of its three most recent fiscal years; Section 1003(a)(ii) with shareholders' equity of less than $4,000,000 and losses from continuing operations and/or net losses in three out of its four most recent fiscal years; Section 1003(a)(iii) with shareholders' equity of less than $6,000,000 and losses from continuing operations and/or net losses in its five most recent fiscal years; and Section 1003(a)(iv) with losses which are so substantial in relation to its overall operations or its existing financial resources, or its financial condition has become so impaired that it appears questionable, in the opinion of the Exchange, as to whether the Company will be able to continue operations and/or meet its obligations as they mature. As a result of this lack of compliance, the Exchange's staff has determined to initiate delisting proceedings with respect to the Company's common stock.
The Company has until February 10, 2006 to request an appeal of the Exchange's determination, and plans to request a hearing before a committee of the Exchange. The Company expects that such a hearing would be scheduled within 45 days of its request. There can be no assurance that the Company's appeal will result in the continued listing of its common stock on the Exchange. If its common stock is delisted from the Exchange after the hearing, it would likely trade on the NASD Over the Counter Bulletin Board.
Good Mourning - UPDA NEWS - Canyon Creek Completes Additional Well at Hagler Capps Lime Unit in Coleman County, Texas -- UPDA to Report Production Through Its Updated Website
Business Wire - February 06, 2006 07:59
HOUSTON, Feb 06, 2006 (BUSINESS WIRE) -- Canyon Creek Oil & Gas Inc. has completed its workover and is preparing to turn to sales the #3 Hagler Capps Lime Unit well located in the Hagler Capps Lime Field in Coleman County, Texas, as the Universal Property Development and Acquisition Corporation (OTCBB:UPDA) subsidiary continues its program to revitalize the oil and gas wells located on its leases in Texas.
The Hagler Capps Lime Field is comprised of 2 leases and 17 wells. Canyon Creek is currently producing 3 wells on the East Hagler lease and 1 well on the Hagler Capps Lime lease. The produced fluids will be pumped to a field separator and the oil will be delivered to the stock tank for sale.
Canyon Creek has already received a permit and will begin to inject produced water into the oil sand at the number 1-B East Hagler well to increase production on the east side of the field. The Company has successfully tested the 1-B Hagler for water injection and the Company has scheduled a meeting with the Railroad Commission of Texas field supervisor who will confirm the results. Field salt water captured from the field separating units will be piped to the 1-B Storage facility for injection.
Once water is injected into the number 1-B Hagler well, production should increase to 1,000 bo/m and 3,000 mcfg/m within 90 days.
As previously reported, Continental Oil Company, predecessor to ConocoPhillips, discovered the Hagler Capps Lime Field in 1954 and the field has a cumulative production of over 1,140,000 barrels of oil. The oil produced from the Capps lime formation is found between 1,900 and 2,000 feet below the surface. Continental successfully initiated water flood procedures on the west side of the field to enhance oil recovery soon after the field was discovered but water flood procedures were never utilized on the east side of the field where 3 wells still produce oil free of water.
The production from this field, as well as the production from all of its properties, will be reported by UPDA as it continues to improve and enhance its website at www.universalpropertydevelopment.com.
About UPDA
UCPJ up 15%
NMKT _ News _ NewMarket Technology Inc. Releases Homeland Security Plan for $10 Million in 2006 Revenue Booked to Proposed Defense Technology Systems; Homeland Security Plan is Last of Six Business Unit Plans Released
Business Wire - February 03, 2006 09:23
DALLAS, Feb 03, 2006 (BUSINESS WIRE) -- NewMarket Technology Inc. (OTCBB:NMKT) today released its 2006 business plan for the Homeland Security sector. The Company has now released plans for all of its business units, including operations in China and Latin America.
NewMarket's Homeland Security business unit plan is unique from its other units. In 2005, NewMarket moved its Homeland Security assets into a separate publicly listed company, Defense Technology Systems (OTC:DFTS). NewMarket is a preferred shareholder of Defense Technology Systems. Based on planned acquisitions, Defense Technology Systems anticipates $10 million in revenue in 2006. Defense Technology Systems' current business plan centers on the planned acquisition of a wireless broadband company offering wireless solutions to municipal governments.
NewMarket is an innovative company that introduced a business model three years ago that offers a unique approach to business technology innovation. The Company combines a traditional systems integration offering with emerging technology incubation. The incubation function includes the eventual independent public listing of "next stage" incubated technologies.
Mr. Philip Verges, CEO of NewMarket, said, "Although NewMarket maintains a conservative forecast of 15% revenue growth overall in 2006, our business unit plans that we have released incorporate attainable revenue goals that clearly would necessitate upward revisions in the revenue growth forecast as corporate developments are announced. After each fiscal quarter financial results are filed, the annual forecast will be reviewed and updated."
The overall result of NewMarket's business technology innovation model has been three years of rapid, profitable growth from $2.3 million in revenue in 2003 to over $50 million in 2005 (un-audited). NewMarket was named in 2005 as the 13th fastest growing technology firm in North America on the Deloitte Technology Fast 500.
About NewMarket Technology Inc. (www.newmarkettechnology.com)
NewMarket Technology Inc. is a Systems Innovation Company. NewMarket has combined a traditional systems integration and support services capacity with a specialized asset-based approach to assisting its clients with the delicate balance between maintaining legacy systems and gaining a competitive edge from the latest technology innovations. NewMarket provides certified integration and maintenance services to support the prevailing industry standard solutions to include Microsoft (Nasdaq:MSFT), Cisco Systems (Nasdaq:CSCO) and Sun Microsystems (Nasdaq:SUNW). Concurrently, NewMarket continuously seeks to acquire undiscovered emerging technology assets to incorporate into an overall product portfolio carefully packaged to complement the prevailing industry standard solutions. NewMarket's emerging technology portfolio includes products for the Telecommunications, Healthcare, Homeland Security and Financial Services industries. NewMarket delivers its portfolio of products and services through its global network of Solution Integration subsidiaries in North America, Latin America, China and Singapore. As a Systems Innovator, NewMarket has set itself apart from the systems integration market through the introduction of a technology business model that monetizes the value of emerging technologies to improve corporate profits and enhance shareholder value with the regular issue of dividends. NewMarket recently announced that it ranked Number 13 on the 2005 Deloitte Technology Fast 500, a ranking of the 500 fastest growing technology companies in North America. Rankings are based on the percentage of revenue growth over five years from 2000-2004. NewMarket's revenue increased 18,082 percent during this period.
This press release contains statements (such as projections regarding future performance) that are forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those projected as a result of certain risks and uncertainties, including but not limited to those detailed from time to time in the Company's filings with the Securities and Exchange Commission.
SOURCE: NewMarket Technology, Inc.
NewMarket Technology, Inc., Dallas
Rick Lutz, Investor Relations, 404-261-1196
ir@newmarkettechnology.com
www.newmarkettechnology.com
Copyright Business Wire 2006
--------------------------------------------------------------------------------
Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision.
Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
GLTA - I can't find that symbol - LOL
CLN - News - Boston Scientific Releases Second Installment of Loan To Celsion; Boston Scientific Agrees to Release the Second, US$4.5 Million, Installment of US$15 Million Loan
same hear in eastern CT, but better than snow, warm winter so far
GLGS- . Announces Chapter 11 Filing, Reduction In Work Force And Senior Management Changes>GLGS GlycoGenesys, Inc
Good Mourning TTOON, Stockz4O, and all
GBIW _ NEWS Genesis Bioventures Announces Breast Cancer Marker Receives Diagnostic and Therapeutic Patent Approval
PR Newswire - February 02, 2006 09:30
NEW YORK, Feb 02, 2006 /PRNewswire-FirstCall via COMTEX/ -- Genesis Bioventures, Inc. (OTCBB:GBIW) announced today that Mammastatin, the breast cancer marker exclusively licensed to its wholly-owned subsidiary, Biomedical Diagnostics, LLC (Biomedical), has been granted additional patent protection through a Deed of Letters Patent recently issued to the University of Michigan by the Australian Patent Office.
Biomedical is currently developing the Mammastatin technology for use in its Mammastatin Serum Assay (MSA), a breast cancer risk assessment tool.
"We are very pleased with this positive development for Biomedical," said Douglas C. Lane of Experigen Management Company. "Not only does patent grant allow Biomedical to offer its proprietary MSA test in Australia, where one in eleven women of the ten million women population will develop breast cancer during their lifetime, it further validates the global patentability of the Mammastatin technology."
"This is one piece of the domestic and international intellectual property protection strategy we have implemented with the University of Michigan," noted Jim Arthurs, president of Biomedical. "The issuance of this patent is very important as we gain further regulatory approval and market presence for the Mammastatin technology internationally. This newest patent grant expands our worldwide patent protection for MSA."
The MSA was initially developed at the University of Michigan Cancer Center and is licensed exclusively to Biomedical by the university through Genesis Bioventures for scientific and commercial development as a blood test to assess women's health. In scientific correlation studies women who tested high with the MSA assay showed to have lower risk of breast cancer than women who tested low.
More information about Biomedical Diagnostics and the MSA test can
Symbol Change CESY to HMSC Homeland Security Capital Corp. Ticker Symbol Changes to HMSC
PR Newswire - February 02, 2006 08:40
ARLINGTON, Va., Feb 02, 2006 /PRNewswire-FirstCall via COMTEX/ -- Homeland Security Capital Corp. (OTC Bulletin Board: HMSC), a company focused on acquiring, developing and consolidating homeland security-related businesses, announced that its ticker symbol has been changed from CESY to HMSC effective today.
RVMN - News
Raven Moon Prepares 13 New GINA D'S KIDS CLUB(R) Programs for PBS Launch In June
PR Newswire - February 02, 2006 08:31
13 New Programs Never Aired Before Will Bring the Total to 30 Episodes
Feb 02, 2006 /PRNewswire-FirstCall via COMTEX/ -- Raven Moon Entertainment, Inc. (OTC Bulletin Board: RVMN) today announced that in a strategic move towards a June 2006 launch to public television stations, it is preparing 13 new never-before-seen episodes of GINA D'S KIDS CLUB (R).
The 13 new educational programs focus on social graces and developing positive attitudes and habits, learning about safety and the environment, and introducing reading, counting and recognizing sounds. All are presented in a fun and positive manner. Six episodes are in the final stages of editing, including: "Good Manners," "Reach for the Stars," "Cuddle Bug Capers," "Journey to the Land of Dino Bugs," "Rhyming Simon" and "Under the Sea." Seven more episodes are scheduled to begin shooting February 15, 2006. These include: "Learning to Read," "Learning to Count," "Safety First," "What's that Sound," "Sharing," "Puppet Friends" and "Sunrise-Sunset."
About "GINA D'S KIDS CLUB":
"GINA D'S KIDS CLUB" has been hailed by educational leaders such as Dr. Mary Beth Leidman, Ed.D, Media Professor, Indiana University of Pennsylvania, as a viable vehicle in the development of the self-image, social, math and reading skills in young children.
"GINA D'S KIDS CLUB" is one of the best new children's educational programs," stated Dr. Janice K. Battenberg, Educational Child Psychologist.
Miami public television station WPBT has agreed to be public television's presenting station for GINA D'S KIDS CLUB(R) with a targeted June 2006 launch. WPBT Channel 2, Florida's first public television station, serves South Florida and the Miami-Ft. Lauderdale and Palm Beach markets.
"One of the most appealing factors of the show is that it features a positive female role model that helps children connect to their world," said Rick Schneider, president & CEO of WPBT. "Public TV loves to provide diversity in content and role models. We feel that 'Gina D' stands out in the world of children's programs."
American Public Television (APT,) which acquires programming to distribute to public TV stations nationwide, offered GINA D'S KIDS CLUB(R) at its APT Fall Marketplace 2005, held in Palm Desert, CA, November 9-12. Tamara Le, senior manager for exchange and scheduling at APT, said the educational aspects along with the culturally and ethnically diverse characters were appealing. As the presenting station, WPBT's role is to work in conjunction with APT to market and represent GINA D'S KIDS CLUB
LIV News - New Innovative Drugs to Treat Mitochondrial Diseases Exclusively Licensed to Samaritan
Business Wire - February 02, 2006 08:00
LAS VEGAS, Feb 02, 2006 (BUSINESS WIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today, it has agreed to exclusively license "Use of Spirostenols to treat Mitochondrial Disorders" from Georgetown University.
Mitochondria are specialized compartments present in every cell of the body, except red blood cells and are responsible for generating over 90% of the energy needed to sustain life. Diseases thought to involve mitochondria impairment are Alzheimer's, Parkinson's, Multiple Sclerosis, and conditions such as, neuronal death induced by stroke, traumatic brain injury, seizures and spinal cord injury, among many others.
Dr. Janet Greeson, CEO of Samaritan Pharmaceuticals stated, "We are extremely pleased with our collaboration with Georgetown University, it gives us the ability to continually, build and grow, our pipeline of innovative drugs. The future, and our future, is dependent on innovation, and I feel 100% confident our shareholders will be kindly rewarded for being patient with us as we build and grow Samaritan."
Samaritan Pharmaceuticals: "We LIV....to Save Lives."
Samaritan Pharmaceuticals is a drug development company driven to discover, develop, and commercialize, innovative therapeutics' for AIDS, Alzheimer's, Cancer and Heart disease. Samaritan, in collaboration with Georgetown University, is advancing eight promising compounds, out of its rich pipeline of 250 possible drug candidates, all of which have the potential to create revenue-generating opportunities. Additional information is at www.samaritanpharma.com.
Disclaimer
DJSW looks interesting, with News might come back to life
I thought You were talking about Sienfeld,s Cramer LOL
wolv, otd, pocc, but just watching at the moment
BKHM Thanx
And Good Mourning All
IGTG _ News Ingen Technologies, Inc. Leading News Agency Reports on Secure Balance(TM)
PR Newswire - February 02, 2006 07:15
- 800 Television Stations and 70 Million Viewers -
CALIMESA, Calif., Feb 02, 2006 /PRNewswire-FirstCall via COMTEX/ -- Ingen Technologies, Inc. (OTC: IGTG), a medical device manufacturer of OxyAlert(TM), OxyView(TM), and Secure Balance(TM), announces that the company has signed a contract with Max World News to film and develop a news story about the Secure Balance(TM) products for over 800 television stations worldwide.
"Rosalind Sedacca, Senior Television News Reporter for Max World News had contacted us after she had learned about our Secure Balance(TM) products and how they have helped thousands of people with balance problems," said Chris Wirth, Director of Ingen Technologies.
The Boynton Beach, Florida based MAX World News is a world-leading newsgathering and delivery service and is recognized as the "one-source" for news delivery. When it comes to producing compelling news stories, their award winning, nationwide network of seasoned television professionals create the impact to get the job done. Max World News has aired stories on every major television network in the United States including, ABC, NBC, CBS, FOX, CNN and CNBC among others and have been seen in over 210 countries around the world, and has personal relationships with health, technology, and consumer interest editors, producers and reporters at every major network in the United States. MAX World News communicates directly with stations to effectively cover breaking news and plan newscasts around observances, seasonal topics and current events.
"This is a very important part of our consumer awareness program. With the "Today's Health" news story about our company being produced next quarter to over 70 million viewers, hospitals and medical professionals; in combination with an unexpected news report being developed by Max World News; our company and the viewers stand to benefit a great deal. Our Secure Balance program can help millions of suffering people, and save billions of dollars spent each year from our Health & Welfare Federal Budget," said Scott Sand, Chairman & CEO of Ingen Technologies.
About Ingen Technologies, Inc.
Ingen Technologies, Inc. is a public company trading under NASDAQ OTC: IGTG, which has been in business since 1999. IGTG is a medical device manufacturer and a growth-oriented company that owns US patent(s), trademarks, and proprietary medical products.
The Company's flagship product is OxyAlert(TM), a second-generation design of the Company's BAFI(TM) product line. Both of these products have been issued two US Patents: Patent No. 6,137,417 issued on October 24, 2000 and Patent No. 6,326,896 issued on December 4, 2001. Both of these products are low-oxygen safety warning devices used on remote oxygen cylinders for patients, commercial aircraft, military transport, and fire and safety equipment. OxyAlert(TM) technology encompasses the use of digital sensing and RF frequency transfer so that care givers can access a hand-held remote to monitor the actual oxygen level of any oxygen cylinder at a reasonable distance.
The newest product, OxyView(TM), has a patent pending, and is a pneumatic gauge that provides visual safety warning of oxygen flow for patients in the hospital, surgical room, outpatient therapy, nursing homes and emergency response facilities. This product enhances the safety, assurance and accuracy of patients being administered oxygen from any source. OxyView(TM) is a lightweight pneumatic gauge that is attached to the oxygen tubing just below the neck. It informs the nursing staff of the oxygen flow rate near the patient. It could quickly inform the physician or technician of any leak or inaccuracy between the delivery source and the patient.
The Secure Balance(TM) product is a private-label product that includes a vestibular function testing system and balance therapy system. The vestibular function testing system is manufactured by Interacoustics LTD. in Denmark and is referred to as the VNG. The balance therapy system is manufactured by SportKAT(R), Inc. in San Diego, California. The Secure Balance(TM) program provides equipment, education and training about balance and fall prevention to physicians and clinicians worldwide.
The Pure Produce(TM) product is a continuing research & development program currently under design. This program uses hydroponics technology to grow various plants without the use of soil, fertilizer and water consumption. The Company anticipates entering the nutriceutical and pharmaceutical markets over the next two years.
"Our team of professionals has developed our medical products for the ever-increasing elderly population. Our products are superior to any of our competition and they allow for effective medical product availability to seniors, and at the same time the increasing senior population allows for a steady growth in sales and profits," said Scott Sand, CEO & Chairman of Ingen Technologies.
For more information, visit www.ingen-tech.com
VLRX - IPO - Valera Pharma $9/Share 3.75M-Shares >
NEW YORK (Dow Jones)--Valera Pharmaceuticals Inc.'s 3.75 million-share initial public offering priced at $9 a share Wednesday evening.
The company allowed underwriters an overallotment option of 562,500 shares. The company had expected to price its IPO at $10 to $12 a share.
UBS Investment Bank, Banc of America Securities, First Albany Capital and Fortis Securities were listed as the offer's underwriters.
The offer has a gross spread of 63 cents, a selling concession of 37.8 cents and a management fee of 12.6 cents.
The offer's underwriting fee is also 12.6 cents and the offer settles Tuesday.
Valera, based in Cranbury, N.J., develops products to treat urological and endocrine conditions, diseases and disorders.
Valera plans to list its common stock on the Nasdaq National Market under the symbol VLRX.
All the Luck in the World To You !!!
Were Lucky to Have You, there Chief
Chris
BGES NEWS - Encouraging Data in HIV Vaccine
OAK BROOK, Ill., Feb 01, 2006 (BUSINESS WIRE) -- Bio-Bridge Science Inc. (OTCBB:BGES), a development-stage biotech company, reported encouraging results for pharmacological and acute toxicity studies on its HIV therapeutic Vaccine (HIV-PV pseudovirus) on mice and monkeys.
The vaccine, based on exclusive technology co-developed by CEO Liang Qiao, an associate professor at Loyola University Chicago's Stritch School of Medicine, targets infection in mucosal tissues, the first type of tissue attacked by HIV.
The studies showed that the vaccine at low, medium and high doses did not have any side effects on the central nervous system, the cardiovascular system or the respiratory system of the animals. No significant differences on blood cells and serum biochemical parameters between pre and post treatment groups were observed within 14 days after treatment.
Dr. Liang Qiao, Chairman and CEO of Bio-Bridge Science, said, "We are very pleased with the initial results of the pre-clinical trials for our HIV Vaccine. We are looking forward to receiving additional results in coming weeks prior to commencing Phase 1 studies."
About Bio-Bridge Science
Bio-Bridge Science is a biotechnology firm focused on the development of vaccines with broad therapeutic and preventive applications. Through its wholly owned subsidiary in Beijing, Bio-Bridge is developing a promising new HIV Vaccine, that is expected to enter clinical trials in China in the very near future. The vaccine, based on exclusive technology co-developed by CEO Liang Qiao, an associate professor at Loyola University Chicago's Stritch School of Medicine, targets infection in mucosal tissues, the first type of tissue attacked by HIV.
The Chinese government, mindful of the rapid expansion of AIDS in China has, through the "Green Mile Policy" acted to expedite the approval of domestically produced HIV Vaccines and has dramatically increased its spending on AIDS-related research. In accordance with this policy, Bio-Bridge expects to bring its therapeutic HIV Vaccine to market as early as 2008, far in advance of many other HIV Vaccines currently in development. Bio-Bridge is currently constructing a new $3 million state-of-the-art GMP research and manufacturing facility in Beijing, which is expected to be completed in early 2006.
BKGD News - to Acquire Four Oil & Gas Properties In Midwest
Business Wire - February 01, 2006 11:00
FORT LAUDERDALE, Fla., Feb 01, 2006 (BUSINESS WIRE) -- Black Gold Gas & Oil, Inc. (Pink Sheets:BKGD) today announced that they have signed a letter of intent with Jones & Buck Development for the acquisition of approximately 41 gas and oil leases in Kansas and northern Oklahoma. The oil and gas leases encompass approximately 8,000 acres in the Cherokee basin of southeastern Kansas including all production, all oil and gas properties and related mineral rights ("collectively the leases"). The leases are currently producing approximately $200,000 per month. With the reworking of some of the wells along with the 2 new offset oil wells and continuous drilling, Black Gold expects that production could increase significantly over the next several months.
As part of its preliminary due diligence, a site visit of the properties was conducted by a company officer in which he viewed the production, the equipment and the properties. In accordance with the Letter of Intent due diligence is to be completed and a final Definitive Purchase Agreement is to be drawn up within a 90 day time period.
Upon the signing of the Definitive Purchase Agreement the purchase price of the acquisition is $4.25 million. This includes current production along with production equipment, which consists of pumping units, down hole equipment, separators, storage tanks and other misc. equipment such as salt water pumps, gas meters, etc.
In connection with the LOI, the company has retained the services of Mr. Bill Foster, President of Manhattan IP, to conduct the due diligence necessary for the acquisition. Mr. Foster has 40 years of experience in the gas and oil business and his resume can be found on Black Gold's web site.
Black Gold is also in the process of hiring an auditing firm out of Oklahoma with a history and background of auditing oil and gas leases and equipment to assist Mr. Foster in his due diligence.
"If the acquisition is completed, the 2 new offset wells, the recompletion of several of the oil wells and the drilling of several new wells should substantially increase the production of leases," reported the company officer who visited the site.
Black Gold Gas & Oil, Inc. is an independent natural resource company focused on the exploration and development of prolific oil and gas properties and valuable timberlands
More TGC News Gross Oil Production 39,690 Barrels
02/01/2006
Dow Jones News Services
(Copyright © 2006 Dow Jones & Company, Inc.)
(MORE TO FOLLOW) Dow Jones Newswires
02-01-06 0958ET
Copyright (c) 2006 Dow Jones & Company, Inc.
DJ Tengasco 4Q Gross Oil Prod From Kan. Ppties 39,690 Barrels
WASHINGTON (Dow Jones)--Tengasco Inc. (TGC) disclosed Wednesday that gross oil production from its Kansas properties during the fourth quarter totaled 39,690 barrels.
The energy company also said in a document filed with the Securities and Exchange Commission that gross production for December 2005 amounted to 15,023 barrels.
Tengasco said that the production levels for both the quarter and the month of December were the largest since 1997.
The company said its net interest in Kansas oil production was 28,599 barrels for the quarter ended Dec. 31, 2005, and 10,825 barrels for December.
"Tengasco's efforts to increase total oil production and re-energize our core assets are proving successful. This is a result of both our ongoing workover program and new drilling," according to Chief Executive Jeffrey R. Bailey.
-By Chad Clinton, Dow Jones Newswires; 202-862-1349; chad.clinton@dowjones.com
UPDA News - Canyon Creek's Reports Six New Wells Producing in Archer County Regular Field
Business Wire - February 01, 2006 10:31
HOUSTON, Feb 01, 2006 (BUSINESS WIRE) -- Canyon Creek Oil and Gas, Inc., a joint venture of Universal Property Development and Acquisition Corporation (OTCBB:UPDA) and USProduction and Exploration, LLC. (USPX), has increased its oil production by an additional 600 barrels of oil per month as six new wells in it Archer County Regular Field are turned to sales. Four of the six new wells are classified as pumping wells and the other 2 wells are flowing 100% oil through the casing. The 5 wells originally producing in Archer County continue generating 2000 barrels of oil per month.
Canyon Creek will continue to monitor the five original and the six new wells for additional increases in oil production. It is expected that the 4 pumping wells will add more oil once the water is pumped off. The Archer County Field represents 1 of the 7 oil and natural gas fields owned by Canyon Creek.
As previously reported, Canyon Creek has also unexpectedly found considerable gas pressure on the casing annulus of these wells. The Company is making plans to lay a gathering system to each well and deliver the gas to the purchaser. The management is in communication with the gas purchaser to connect the wells to a sales pipeline.
Canyon Creek also reports today that the #2 Prideaux located in South Markley Field, in Young County, Texas, is now making 3,780 mcfg/m and 45 bo/m. The #2 Prideaux was making 90 mcfg/m and no oil when Canyon Creek purchased the lease and the well. Following a work-over that include lowering rods and a down-hole pump in the well, moving in and connecting a 114 pump jack, and setting a compressor vacuum pump to move additional gas to the pipeline, the Company has increased the production revenue 4,200 percent.
Work on Canyon Creek's 17 wells in Coleman County, Texas and its 27 wells in Palo Pinto County, Texas is also proceeding as scheduled. "We will continue to bring more wells on-line and continue to increase revenues in the days and weeks ahead," reports Donald Orr, President of Canyon Creek. "We have these 44 wells that are currently in the process of workover as well as the major gas well in Victoria County, Texas that we are working to complete and produce."
About UPDA
Universal Property Development and Acquisition Corporation (OTCBB:UPDA) focuses on the acquisition and development of proven oil and natural gas reserves and other energy opportunities through the creation of joint ventures with under-funded owners of mineral leases and cutting-edge technologies.
For additional information visit: www.universalpropertydevelopment.com .
About CCOG
Canyon Creek Oil & Gas Inc. was formed in July 2005 as a joint venture corporation for the purpose of acquiring currently producing oil and gas properties, low risk drilling prospects and existing wells in need of state-of-the-art technology to improve profitability. Canyon Creek Oil and Gas Inc. now has over 60 wells located on more than 2,000 acres in the Fort Worth basin. The Company has also acquired properties located in Inez Field in Victoria County and Giddings Gas Field in Fayette County, Texas. Canyon Creek continues a revitalization program on all of its properties in order to improve production and bring more wells on line.
About USPX
USProduction & Exploration, LLC, an independent production and exploration company located in Sugar Land, Texas, is engaged in the acquisition of oil and gas producing properties with multiple enhancement opportunities. USPX seeks high quality exploration drilling projects in conventional and unconventional reservoirs. The Company's approach to developing depleted reservoirs and unconventional gas is innovative: it combines horizontal, multilateral, with under balanced drilling methods.
Statements contained in this press release that are not based upon current or historical fact are forward-looking in nature. Such forward-looking statements reflect the current views of management with respect to future events and are subject to certain risks, uncertainties, and assumptions. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, or described pursuant to similar expressions.
SOURCE: Canyon Creek Oil and Gas, Inc.
Universal Property Development and Acquisition
Corporation
Bradford Moore, 561-630-2977 (Investor Relations)
info@updac.com
Copyright Business Wire 2006
--------------------------------------------------------------------------------
Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision.
Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
TGC News Kansas Production Increases and Developments
Business Wire - February 01, 2006 09:55
KNOXVILLE, Tenn., Feb 01, 2006 (BUSINESS WIRE) -- Tengasco, Inc. (AMEX:TGC) announced today that in December 2005 and the quarter ending December 31, 2005 the Company produced more oil from its Kansas properties both in a single month and in a calendar quarter than it produced in any similar period since 1997. The Company's gross production for the month of December 2005 of 15,023 barrels was the largest since mid-1997. The Company's net interest in December 2005 production was 10,825 barrels. The gross production in the fourth quarter of 2005 of 39,690 barrels was the largest since the fourth quarter of 1997, which was in the first year of production after Tengasco purchased its Kansas properties. The Company's net interest in Kansas oil production in the quarter ending December 31, 2005 was 28,599 barrels.
Tengasco's CEO Jeffrey R. Bailey said: "Tengasco's efforts to increase total oil production and re-energize our core assets are proving successful. This is a result of both our ongoing workover program and new drilling. We are optimistic that the strategies we have applied will continue to boost production and improve the Company's oil reserves. We are acquiring new acreage, focusing on finishing the Company's eight and twelve well drilling programs as soon as possible, and positioning the Company for long term production growth and reserve building. That strategy also requires a dynamic exploration and development team. Tengasco is happy to announce the addition of Rod Tremblay as Senior Geologist to lead our growth efforts in Kansas."
Mr. Tremblay earned a B.S. degree in Geology from Fort Hays State University in 1981 and in 1990 earned an M.S. degree in Geology. He was employed as a staff geologist by the Roxanna Corporation from 1981 until 1984. He started his own consulting firm and oil and gas firm in 1984 and continued in that capacity until 1991. Since 1991, he has been a geologist in the Mid-Continent and Rocky Mountain regions, except for a brief stint in Nevada with the U.S. Geological Survey on the Yucca Mountain Project. He is also an adjunct professor with the University of Nebraska, Geological Survey. Mr. Tremblay joined the Company in November, 2005.
The Company intends to file its Annual Report on Form 10-K for the year ended December 31, 2005 together with the Company's audited financial statements for that period in March 2006.
EAG News Eagle Broadband Awarded Patent for SatMAX Satellite Communications Technology
Business Wire - February 01, 2006 09:45
HOUSTON, Feb 01, 2006 (BUSINESS WIRE) -- Eagle Broadband (AMEX:EAG), a leading provider of broadband, Internet protocol (IP) and communications technology and services, announced today that the company has received notification from the U.S. Patent and Trademark Office that Patent # 6,996,369 has been awarded to the company and will be issued on or about February 7, 2006 for its SatMAX(TM) non-line-of-sight, satellite communications technology.
"We are very pleased to have received this patent for our non-line-of-sight satellite-based communications technology," said Dave Micek, president and CEO of Eagle Broadband. "Because of the heightened focus on reliable communications for emergency response during natural and man made disasters, the need for satellite-based communications is broadening from its traditional military and corporate applications. Protecting our intellectual property is more important than ever and this patent provides a strong footing for our efforts to expand SatMAX deployments and market applications."
Eagle's exclusive fixed and portable SatMAX non-line-of-sight satellite communications technology enables civilian government, military and enterprise customers to quickly and easily make reliable, fully wireless, voice and data communications available in any non-line-of-sight environment including inside buildings or structures, onboard vehicles, aircraft or ships. With SatMAX, users of the Iridium satellite network can use their existing satellite phones to make multiple concurrent calls within SatMAX-enabled "hotspot" areas from any location on Earth. The technology enables routine, mission critical and backup communications that can improve safety and security, emergency preparedness and response, user productivity, mobility, problem solving and mission support. In its portable configuration, SatMAX can be deployed in minutes, easily transported and can operate either on batteries or standard AC power allowing users with existing Iridium handsets to quickly and easily make secure calls from virtually any location.
About Eagle Broadband
Eagle Broadband is a leading provider of broadband, Internet Protocol (IP) and communications technology and services that create new revenue opportunities for broadband providers and enhance communications for government, military and enterprise customers. Eagle leverages years of proven experience delivering advanced, IP-based broadband services to provide service provider partners with a way to deliver next generation entertainment, communications and security services to their subscribers. The company's product offerings include IPTVComplete(TM) the fastest, lowest cost way for broadband providers to deliver the most competitive IP video services, the MediaPro line of HDTV-ready IP set-top boxes that enable broadband providers and hotel operators to maximize revenues by delivering state-of-the-art, interactive entertainment services and the SatMAX(TM) satellite communications system that provides government, military, homeland security and enterprise customers with reliable, non-line-of-sight, voice and data communications from any location on Earth. The company is headquartered in Houston, Texas. For more information, please visit www.eaglebroadband.com or call 281-538-6000.
Sontra Serves Patent Infringement to Dermisonics
Sontra Medical Serves Patent Infringement Notice for Dermisonics' Transdermal Insulin Delivery System
PR Newswire - February 01, 2006 09:00
FRANKLIN, Mass., Feb 01, 2006 /PRNewswire-FirstCall via COMTEX/ -- Sontra Medical Corporation (Nasdaq: SONT) announced today that it has sent a notice to Dermisonics, Inc. (OTC Bulletin Board: DMSI.OB) stating Sontra's belief that, upon commercialization, Dermisonics' U-Strip ultrasonic transdermal delivery system for insulin and other drugs will infringe one or more of Sontra's patents. On February 1, 2006, Sontra sent a letter to Dermisonics stating that Sontra believes that the U-Strip system currently infringes, or will infringe, the claims in Sontra's U.S. patent numbers 6,002,961, 6,190,315, and/or 6,491,657, noting that the penalties for such infringement are severe, including a preliminary and permanent injunction, treble damages and attorneys' fees. Such letter follows several earlier letters and communications by Sontra to Dermisonics over the past several months regarding this matter. Sontra has offered to negotiate the terms of a mutually agreeable license agreement with Dermisonics, but has to date received no response.
Thomas W. Davison, Sontra's President and Chief Executive Officer, stated, "We are very concerned that Dermisonics is or very soon will be infringing on our patents with its U-Strip system for the transdermal delivery of insulin and other drugs. As both companies share mutual interests in the areas of diabetes management and drug delivery, we have offered to license our technology to Dermisonics, but have not yet received from them any indication of a willingness to establish fair license terms. Sontra takes this matter very seriously and will take all necessary actions to protect our intellectual property and Dermisonics is on notice that the U-Strip system has serious patent infringement concerns."
About Sontra Medical Corporation (http://www.sontra.com)
Sontra Medical Corporation is a technology leader in transdermal science. Sontra's SonoPrep ultrasound-mediated skin permeation technology combined with technical competencies in transdermal drug formulation, delivery systems and biosensors is creating a new paradigm in transdermal drug delivery and diagnosis. The SonoPrep technology is being developed for several billion dollar market opportunities, including continuous glucose monitoring and the transdermal delivery of large molecule drugs and vaccines. Sontra is currently marketing the SonoPrep device and procedure tray for use with topical lidocaine to achieve rapid (within five minutes) skin anesthesia.
Contact:
Sean Moran, Sontra Medical CFO
508-530-0334
SonoPrep is a registered trademark of Sontra Medical Corporation. All other company, product or service names mentioned herein are the trademarks or registered trademarks of their respective owners.
This press release contains forward-looking statements, which address a variety of subjects including, for example, the expected benefits and efficacy of the SonoPrep device in connection with diagnostics, vaccine delivery, glucose monitoring and transdermal drug delivery, Sontra's expected ability to develop, market and sell products based on its technology, the expected size of the markets for the SonoPrep device and technology, Sontra's ability to license its technology to Dermisonics, and Sontra's business, research, product development, regulatory approval, marketing and distribution plans and strategies. Statements that are not historical facts, including statements about our beliefs and expectations, are forward-looking statements. Such statements are based on our current expectations and are subject to a number of factors and uncertainties, which could cause actual results to differ materially from those described in the forward-looking statements. The following important factors and uncertainties, among others, could cause actual results to differ materially from those described in these forward- looking statements: our technology is new and we may experience adverse results in research collaborations, product development, clinical trials, product evaluations, commercialization efforts, product distribution and market acceptance; markets for our products may develop slower than expected, or not at all; our sales cycle is lengthy and we are still developing sales and marketing strategies which may or may not prove effective; the SonoPrep device may not prove effective in connection with diagnostics, vaccine delivery, glucose monitoring and/or transdermal drug delivery; we may experience difficulties or delays in obtaining regulatory approvals to market products resulting from development efforts or difficulties or delays associated with sources of regulatory-approved transdermal drugs and vaccines; failure to obtain and maintain patent protection for discoveries or commercial limitations imposed by patents owned or controlled by third parties would have an adverse effect on us; we depend upon strategic partners and third-party distributors to develop, commercialize, market and sell products based on our work; and we require substantial additional funding to conduct research and development and to expand commercialization, distribution and marketing activities. For detailed information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to Sontra's filings with the Securities and Exchange Commission, including Sontra's most recent Quarterly Report on Form 10-QSB. Forward-looking statements represent management's current expectations and are inherently uncertain. We do not undertake any obligation to update forward- looking statements made by us.
SOURCE Sontra Medical Corporation
Sean Moran, CFO of Sontra Medical, +1-508-530-0334
http://www.prnewswire.com
Copyright (C) 2006 PR Newswire. All rights reserved. ********************************************************************** As of Saturday, 01-28-2006 23:59, the latest Comtex SmarTrend(SM) Alert, an automated pattern recognition system, indicated a DOWNTREND on 08-10-2005 for SONT @ $1.50. (C) 2006 Comtex News Network, Inc. All rights reserved.
--------------------------------------------------------------------------------
Copyright © 2006 MarketWatch, Inc. All rights reserved. Please see our Terms of Use. MarketWatch, the MarketWatch logo, and BigCharts are registered trademarks of MarketWatch, Inc.
News provided by Dow Jones NewswiresSM, PR News Wire™ and Business Wire™. Dow Jones Newswires is a service mark of Dow Jones & Company. PR News Wire is a Trademark of PR Newswire Association, Inc. Business Wire is a registered trademark and service mark of Business Wire.
Ameritrade is not responsible for the quality and suitability of third party financial or investment information or services. Please consult other sources of information and consider your individual financial position and goals before making an investment decision.
Ameritrade, Division of Ameritrade, Inc., member NASD/SIPC. Ameritrade and Ameritrade logos are trademarks or registered trademarks of Ameritrade IP Company, Inc. 2002 Ameritrade IP Company, Inc. All rights reserved. Used with permission.
ARTX News Receives $700,000 Follow-on Order for New Light Weight Battery
Business Wire - February 01, 2006 08:28
AUBURN, Ala., Feb 01, 2006 (BUSINESS WIRE) -- Arotech Corporation (NasdaqNM:ARTX) announced today the receipt of an order valued over $700,000 from the U.S. Army's Communications and Electronic Command (CECOM). The order for the BA-8140/U zinc-air battery along with adapters for the Javelin guided missile launcher, the M22 ACADA chemical detector and the SatCom radio, all belonging to Arotech's Electric Fuel subsidiary, follows the successful introduction of the new lightweight battery by the Army through a recently received initial order. The new battery will be used by the Army to power MBITR radios and other 12V applications.
"This second substantial order for these recently-released products is further indication of the growing acceptance of Zinc-Air as a portable energy solution of choice with our Warfighters," said Graydon Hansen, President and General Manager of Arotech's Electric Fuel Battery Corporation subsidiary.
Arotech is the sole supplier of zinc-air batteries to the U.S. Army and has delivered tens of thousands of its BA-8180/U zinc-air batteries to date. The new Electric Fuel BA-8140/U zinc-air battery is a 12 Volt, 400 Watt-hour, non-rechargeable battery pack, approximately half the size and weight of the BA-8180/U. The BA-8140/U battery complements the existing BA-8180/U battery, each serving different applications. Both batteries serve as mission extenders by having a higher energy density.
"This follow-on order was received within a short time after the initial order for our new lightweight batteries, reinforcing our leadership in zinc-air technology," said Robert S. Ehrlich, Chairman and CEO of Arotech. "We are committed to continuing to serve the Army with a safe and cost-effective technology that enhances the soldiers' extended mission capabilities."
Zinc-air batteries are considerably safer in combat situations, lighter for extended missions, more economical and more environmentally friendly than lithium batteries.
Arotech's Battery and Power Systems Division is a leading provider of zinc-air and rechargeable batteries and chargers for defense and security products and other military applications. Arotech develops and produces high power zinc-air batteries and is believed to be the sole supplier of this technology to the US military. In addition, Arotech develops high-end primary and secondary batteries and associated chargers and has vast experience in working with government agencies, the military and large corporations. The division also pioneers advancements in zinc-air technology for electric vehicles.
The Battery and Power Systems Division consists of Electric Fuel Battery Corporation, Electric Fuel Ltd., and Epsilor Electronic Industries Ltd.